Frovatriptan succinate - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for frovatriptan succinate and what is the scope of freedom to operate?
Frovatriptan succinate
is the generic ingredient in two branded drugs marketed by Endo Operations, Amneal Pharms Co, Glenmark Pharms Ltd, Norvium Bioscience, and Renata, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.There are three drug master file entries for frovatriptan succinate. Four suppliers are listed for this compound.
Summary for frovatriptan succinate
| US Patents: | 0 |
| Tradenames: | 2 |
| Applicants: | 5 |
| NDAs: | 5 |
| Drug Master File Entries: | 3 |
| Finished Product Suppliers / Packagers: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 42 |
| Patent Applications: | 243 |
| What excipients (inactive ingredients) are in frovatriptan succinate? | frovatriptan succinate excipients list |
| DailyMed Link: | frovatriptan succinate at DailyMed |
Pharmacology for frovatriptan succinate
| Drug Class | Serotonin-1b and Serotonin-1d Receptor Agonist |
| Mechanism of Action | Serotonin 1b Receptor Agonists Serotonin 1d Receptor Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for frovatriptan succinate
Paragraph IV (Patent) Challenges for FROVATRIPTAN SUCCINATE
| Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
|---|---|---|---|---|---|---|
| FROVA | Tablets | frovatriptan succinate | 2.5 mg | 021006 | 1 | 2011-03-09 |
US Patents and Regulatory Information for frovatriptan succinate
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Endo Operations | FROVA | frovatriptan succinate | TABLET;ORAL | 021006-001 | Nov 8, 2001 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Renata | FROVATRIPTAN SUCCINATE | frovatriptan succinate | TABLET;ORAL | 213891-001 | Apr 6, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Glenmark Pharms Ltd | FROVATRIPTAN SUCCINATE | frovatriptan succinate | TABLET;ORAL | 204730-001 | Mar 11, 2016 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Norvium Bioscience | FROVATRIPTAN SUCCINATE | frovatriptan succinate | TABLET;ORAL | 202931-001 | Aug 28, 2014 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Amneal Pharms Co | FROVATRIPTAN SUCCINATE | frovatriptan succinate | TABLET;ORAL | 211292-001 | Nov 6, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for frovatriptan succinate
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Endo Operations | FROVA | frovatriptan succinate | TABLET;ORAL | 021006-001 | Nov 8, 2001 | ⤷ Sign Up | ⤷ Sign Up |
| Endo Operations | FROVA | frovatriptan succinate | TABLET;ORAL | 021006-001 | Nov 8, 2001 | ⤷ Sign Up | ⤷ Sign Up |
| Endo Operations | FROVA | frovatriptan succinate | TABLET;ORAL | 021006-001 | Nov 8, 2001 | ⤷ Sign Up | ⤷ Sign Up |
| Endo Operations | FROVA | frovatriptan succinate | TABLET;ORAL | 021006-001 | Nov 8, 2001 | ⤷ Sign Up | ⤷ Sign Up |
| Endo Operations | FROVA | frovatriptan succinate | TABLET;ORAL | 021006-001 | Nov 8, 2001 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
